Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.
第一作者:
Theo,de Witte
第一单位:
Department of Tumorimmunology, Radboud University Medical Centre Nijmegen, Nijmegen, the Netherlands. t.deWitte@ncmls.ru.nl
作者:
主题词
成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);中年人(Middle Aged);骨髓增生异常综合征(Myelodysplastic Syndromes);肿瘤, 继发原发性(Neoplasms, Second Primary);存活率分析(Survival Analysis);移植, 自体(Transplantation, Autologous);移植, 同种(Transplantation, Homologous)
DOI
10.3324/haematol.2009.019182
PMID
20494931
发布时间
2021-10-20
- 浏览39

Haematologica
1754-61页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文